Mayinglong Pharmaceutical Group Stock Co.,Ltd.’s Net Profit Rose 7.8% in First Half of 2023

Mayinglong Pharmaceutical Group Stock Co.,Ltd. (马应龙药业集团股份有限公司) (600993.SH) reported a net profit of 293.7 million yuan in the first half of 2023, up 7.8% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, down 14.9% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 27.3%.